GLPG-3221
GLPG-3221 is an orally bioavailable, potent CFTR corrector with an EC50 of 105 nM, intended for cystic fibrosis research. It is utilized in both in vitro and in vivo experimental models to investigate the rescue of mutant CFTR function and potential therapeutic applications.
Product Specifications
CAS Number
2222264-64-2
Field of Research
Pharmacology & Drug Discovery
Smiles
C (=O) (N1[C@H] ([C@@H] (OCC2=C (OC) N=CC (C (F) (F) F) =C2) [C@H] ([C@] (C) (C) C) [C@H]1C (O) =O) C3=C (C) C=CC=C3) [C@@H]4CCCCO4
Molecular Formula
C30H37F3N2O6
Molecular Weight
578.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV777779 1.0 µg DNA
RPL21P68 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details AMM21723VCF 100 µg
BRUNOL6 (CELF6) Mouse Monoclonal Antibody [Clone ID: LBI1F8]
Sign In for Pricing
View Details 
MBS1022958-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O45:K1 Protein-export protein secB (secB)
Sign In for Pricing
View Details